UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

(Rule 14a-101)

 

INFORMATION REQUIRED IN PROXY STATEMENT

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934

 

(Amendment No.      )

 

Filed by the Registrant ☐

 

Filed by a Party other than the Registrant ☒

 

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Under Rule 14a-12

  

CytRx Corporation

(Name of Registrant as Specified in Its Charter)

 

JERALD A. HAMMANN

(Name of Persons(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

No fee required.

 

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

(1) Title of each class of securities to which transaction applies:

 

 

 

(2) Aggregate number of securities to which transaction applies:

 

 

 

(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

 

(4) Proposed maximum aggregate value of transaction:

 

 

 

(5) Total fee paid:

 

 

 

Fee paid previously with preliminary materials:

  

 

 

☐          Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.

 

 

 

(1) Amount previously paid:

 

 

 

(2) Form, Schedule or Registration Statement No.:

 

 

 

(3) Filing Party:

 

 

 

(4) Date Filed:

 

 

 

 

 

August 21, 2020

The following is the text of an email sent beginning on August 18, 2020, to some former shareholders of CytRx Corporation who may also be current shareholders:

Subject: CYTR Proxy Contest

Hello

I received your name and contact information from a fellow CYTR shareholder. As you may know, CytRx Corporation has scheduled a Shareholder Meeting for September 3, 2020. One of the Board seats is currently contested between me and Mr. Steven Kriegsman, the Company's current CEO and Chairman of the Board.

I am inquiring whether you still own shares in CytRx and whether I can count on your vote at the Shareholder Meeting. I have available on www.noticepapers.com the Proxy Statement I filed with the Securities and Exchange Commission, along with two shareholder letters responsive to various claims made by the Company either in favor of its candidates or against my candidacy.

If you are still a shareholder, after you have had a chance to review these materials, please let me know whether I can count upon your support for my candidacy at the upcoming Shareholder Meeting. Please also let me know your current share count and (if you feel comfortable doing so) with which brokerage you hold your shares.

If you are no longer a shareholder, I would appreciate it if you would please return my email to let me know so that I can remove you from future contact efforts.

Thank you for reading this email. I hope we can build a better future for the shareholders of CytRx Corporation.

Jerry Hammann

(612) 290-7282

    4
CytRx (QB) (USOTC:CYTR)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more CytRx (QB) Charts.
CytRx (QB) (USOTC:CYTR)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more CytRx (QB) Charts.